Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

Veliparib: Ph III data

April 21, 2017 8:31 PM UTC

Top-line data from a double-blind, international Phase III trial in 312 patients with early stage TNBC showed that oral veliparib plus carboplatin and paclitaxel missed the primary endpoint of improvi...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Abbvie Inc.